Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review

BACKGROUND: In patients with hormone receptor-positive breast cancer, differentiating between patients with a low and a high risk of recurrence is an ongoing challenge. In current practice, prognostic clinical parameters are used for risk prediction. DNA methylation markers have been proven to be of...

Descripción completa

Detalles Bibliográficos
Autores principales: de Ruijter, Tim C., van der Heide, Frank, Smits, Kim M., Aarts, Maureen J., van Engeland, Manon, Heijnen, Vivianne C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993426/
https://www.ncbi.nlm.nih.gov/pubmed/32005275
http://dx.doi.org/10.1186/s13058-020-1250-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993426/
https://www.ncbi.nlm.nih.gov/pubmed/32005275
http://dx.doi.org/10.1186/s13058-020-1250-9

Ejemplares similares